Rare Diseases, Drug Development and AIDS: The Impact of the Orphan Drug Act

Michael Henry Davis; Peter S. Arno; Karen Bonuck

Rare Diseases, Drug Development and AIDS: The Impact of the Orphan Drug Act

Michael Henry Davis, Peter S. Arno, Karen Bonuck

Research output: Contribution to journal › Article › peer-review

Abstract

In this article, we examine the Orphan Drug Act with an eye toward its contribution to the public interest, using AIDS drugs to illustrate many of the central points. The major policy question is, How, if at all, can the act be used to meet the legislative goal of stimulating drug development for small patient populations without resulting in prices that make drugs inaccessible?

Original language	American English
Journal	Milbank Quarterly
Volume	73
State	Published - Jan 1 1995

Keywords

rare diseases
drug development
AIDS
drug pricing
Orphan Drug Act

Disciplines

Food and Drug Law
Health Law and Policy

Access to Document

Rare Diseases Drug Development and AIDS The Impact of the OrphaFinal published version, 1.92 MBLicense: CC BY

Cite this

@article{d8cece64c89a470a9555323b4da37fde,

title = "Rare Diseases, Drug Development and AIDS: The Impact of the Orphan Drug Act",

abstract = " In this article, we examine the Orphan Drug Act with an eye toward its contribution to the public interest, using AIDS drugs to illustrate many of the central points. The major policy question is, How, if at all, can the act be used to meet the legislative goal of stimulating drug development for small patient populations without resulting in prices that make drugs inaccessible?",

keywords = "rare diseases, drug development, AIDS, drug pricing, Orphan Drug Act",

author = "Davis, \{Michael Henry\} and Arno, \{Peter S.\} and Karen Bonuck",

note = "Michael Henry Davis, Peter S. Arno and Karen Bonuck, Rare Diseases, Drug Development and AIDS: The Impact of the Orphan Drug Act, 73 Milbank Quarterly 231 (1995)",

year = "1995",

month = jan,

day = "1",

language = "American English",

volume = "73",

journal = "Milbank Quarterly",

}

TY - JOUR

T1 - Rare Diseases, Drug Development and AIDS: The Impact of the Orphan Drug Act

AU - Davis, Michael Henry

AU - Arno, Peter S.

AU - Bonuck, Karen

N1 - Michael Henry Davis, Peter S. Arno and Karen Bonuck, Rare Diseases, Drug Development and AIDS: The Impact of the Orphan Drug Act, 73 Milbank Quarterly 231 (1995)

PY - 1995/1/1

Y1 - 1995/1/1

N2 - In this article, we examine the Orphan Drug Act with an eye toward its contribution to the public interest, using AIDS drugs to illustrate many of the central points. The major policy question is, How, if at all, can the act be used to meet the legislative goal of stimulating drug development for small patient populations without resulting in prices that make drugs inaccessible?

AB - In this article, we examine the Orphan Drug Act with an eye toward its contribution to the public interest, using AIDS drugs to illustrate many of the central points. The major policy question is, How, if at all, can the act be used to meet the legislative goal of stimulating drug development for small patient populations without resulting in prices that make drugs inaccessible?

KW - rare diseases

KW - drug development

KW - AIDS

KW - drug pricing

KW - Orphan Drug Act

UR - https://engagedscholarship.csuohio.edu/fac_articles/748

M3 - Article

VL - 73

JO - Milbank Quarterly

JF - Milbank Quarterly

ER -

Rare Diseases, Drug Development and AIDS: The Impact of the Orphan Drug Act

Abstract

Keywords

Disciplines

Access to Document

Other files and links

Cite this